Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
37.77(c) 37.18(c) 36.86(c) 36.75(c) 36.7(c) Last
47 326 586 47 831 077 31 027 868 30 271 992 33 803 493 Volume
+1.72% -1.56% -0.86% -0.30% -0.14% Change
More quotes
Financials (USD)
Sales 2020 48 571 M - -
Net income 2020 17 066 M - -
Net Debt 2020 43 571 M - -
P/E ratio 2020 13,3x
Yield 2020 3,92%
Sales 2021 53 585 M - -
Net income 2021 14 926 M - -
Net Debt 2021 33 760 M - -
P/E ratio 2021 15,3x
Yield 2021 4,22%
Capitalization 204 B 204 B -
EV / Sales 2020 5,10x
EV / Sales 2021 4,44x
Nbr of Employees 88 300
Free-Float 59,1%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Sector
Pharmaceuticals
Calendar
01/28Ex-dividend day for
More about the company
Notations Surperformance© of Pfizer Inc.
Trading Rating : Investor Rating :
More Ratings
All news about PFIZER INC.
03:55aSwiss to get Moderna vaccine in tranches until mid-year - Blick
RE
01/16PFIZER : Canada surpasses 700,000 confirmed COVID-19 cases as provinces revisit ..
AQ
01/16PFIZER : Ontario reports 3,056 new COVID-19 cases, adjusts vaccine schedule due ..
AQ
01/15PFIZER : Biden to Outline Plans for Bigger Federal Role in Covid-19 Vaccinations..
DJ
01/15PFIZER : Statement by Pfizer Chairman and CEO Albert Bourla
PU
01/15Pfizer says it has second doses of COVID-19 shot on hand, expects no U.S. sup..
RE
01/15Canadian dollar drops, posts weekly decline on greenback short-covering
RE
01/15PFIZER : Vaccine Shortfall to Hit Europe, Canada as Pfizer Plant Is Upgraded
DJ
01/15Pfizer says it has second doses of COVID shot on hand, expects no supply prob..
RE
01/15PFIZER : Anger in states over pace of COVID-19 vaccine allotments
AQ
01/15Italy says Pfizer to cut vaccine supplies by 29% from Monday
RE
01/15Italy's covid-19 special commissioner arcuri says pfizer has said it is not a..
RE
01/15Italy's covid-19 special commissioner arcuri says pfizer has decided to cut b..
RE
01/15BIONTECH : Pfizer to Deliver 'Significantly' More COVID-19 Doses to Europe in Q2..
MT
01/15THE LATEST : Global deaths reach 2 million from coronavirus
AQ
More news
News in other languages on PFIZER INC.
02:01aComprendre l'univers des biotechs, à l'origine des premiers vaccins anti-Covi..
01:31aRevue de presse de ce dimanche 17 janvier 2021
01/16Die Schlagzeilen der Sonntagspresse vom Sonntag, 17. Januar 2021
01/16COVID-19 : retard limité des livraisons de vaccins en Europe, durcissement des
01/16COVID-19 : couvre-feu national sous la neige, la France passe le seuil des 70.
More news
Analyst Recommendations on PFIZER INC.
More recommendations
Stock Trading Strategies
PFIZER INC. - 2020
Close to new upside potential
BUY
More Stock Trading Analysis
Chart PFIZER INC.
Duration : Period :
Pfizer Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 41,94 $
Last Close Price 36,70 $
Spread / Highest target 44,4%
Spread / Average Target 14,3%
Spread / Lowest Target -1,91%
EPS Revisions
Managers and Directors
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Suzanne Nora Johnson Independent Director
Helen H. Hobbs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.-0.30%203 993
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
ABBVIE INC.3.15%195 120